Biolexis and Akston Biosciences announce encouraging results of thermostable 2nd Gen COVID-19 vaccine
An interim analysis of this data shows no significant safety issues and a 91% seroconversion rate at Day 56.
An interim analysis of this data shows no significant safety issues and a 91% seroconversion rate at Day 56.
Sanjay Verma of Akums Drugs & Pharmaceuticals, Manu Gupta of Cadila Pharmaceuticals, Rahul Borse of RPG Life Sciences, Krishna Sai T of Biocon and Amit Saluja of NASSCOM are speakers
It is only the second healthcare provider in the world to attain the Stage 6 DIAM certification.
The states where Polio vaccine drops will be conducted includes: Bihar, Chandigarh, Delhi, Gujarat, Haryana, Jharkhand, Maharashtra, Punjab, Rajasthan, Uttarakhand, and West Bengal
Ganguly will execute company's strategic focus on leveraging CustomGlycan to develop novel therapeutics
Large datasets will train machine learning models and speed up agile discovery of novel crop protection solutions
QIAGEN has started its cloud transformation journey with the firm belief that cloud computing can be a key enabler of future business growth
Site has a capital investment program of ~$30 million spent or committed over the last three years to expand capabilities and improve operational efficiencies
The Ayushman Bharat Digital Mission (ABDM) aims to replicate this success in healthcare delivery by building an equitable, accessible and inclusive ecosystem
Increased and timely testing will enable early identification of COVID cases and help to curb spread of the infection among the community
Subscribe To Our Newsletter & Stay Updated